GCGloria Chepko

Gloria Chepko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gloria Chepko has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Gilbert H. Smith

    Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

    2 shared publications
  • R.B. Dickson

    Department of Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, NRB W 401 3970 Reservoir Road NW, Washington, DC 20057, USA

    2 shared publications
  • Barbara K. Vonderhaar

    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-4254, USA

    1 shared publication
  • Cs Atwood

    Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-2740, USA

    1 shared publication
  • D. Carbott

    Department of Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, NRB W 401 3970 Reservoir Road NW, Washington, DC 20057, USA

    1 shared publication
  • Dezhong J Liao

    Vincent T Lombardi Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington DC 20007, USA

    1 shared publication

Latest Publications

  • Imaging biomarker analysis of rat mammary fat pads and glandular tissues in MRI images

    by Yimo Tao, Jianhua Xuan, Matthew T. Freedman, Gloria Chepko, Peter G. Shields, Yue Wang

    In studying the relationship between risk factors and breast cancer, the growth patterns of fat pads and glandular tissues are considered as important biomarkers. The aim of this study is to measure the growth pattern statistics of rat mammary pads and glandular tissues with magnetic resonance (MR) time sequence images. In this paper, we proposed methods containing sequential steps to extract and analyze imaging biomarkers of rat mammary pad and glandular tissues. Firstly, to accurately segment out pads in MR images with noisy bias filed, we proposed a level set method combining local binary fitting (LBF) and geodesic active contour (GAC). The salient glandular tissue regions within the fat pads are further extracted by a scale-space analysis procedure. Then, the volume data of a single rat at different time points are aligned through profile correlation analysis. Finally, the growth rates are calculated and compared to show the changing patterns of fat pads and glandular tissues within separate groups. The experimental results showed the great utility of this approach in providing accurate measurements for novel risk factors of breast cancer.

  • Breast cancer, stem cells, and the stem cell niche

    by G. Chepko

    At least four cell types in mouse mammary epithelium, three in human, and three in cow are now known to be proliferation competent. Some evidence indicates that pregnancy may confer proliferative competency on a new cell type. These cells are widely seen as stem and progenitor cells that maintain the epithelium and produce lactational units during pregnancy. Evolutionarily conserved developmental signaling pathways active in germinal and neuronal stem cell proliferation and differentiation in drosophila and mammalian development are implicated in mammary tumorigenesis. In adult tissues this signaling is retained, is regulated by stem cell niches and operates to create new tissue and maintain tissue form and integrity. Disruption of this signaling may abrogate maintenance of the stem cell niche and lead to preneoplastic conditions.


  • Mammary epithelial stem cells

    by Gilbert H. Smith, Gloria Chepko

    It has recently been shown that the progeny from a single cell may comprise the epithelial population of a fully developed lactating mammary outgrowth in mice. Serial transplantation of epithelial fragments from this clonally derived gland demonstrates that the subsequently generated outgrowths are also comprised of progeny from the original antecedent. All epithelial cell types were found to be present within these clonal normal populations including luminal, myoepithelial, ductal, and lobule‐committed epithelial progenitors and fully competent mammary epithelial stem cells. These observations demonstrate the presence of multipotent tissue‐specific epithelial stem cells among the parenchyma of the murine mammary gland. Similarly, genetic analysis of contiguous portions of individual human mammary ducts within the same breast indicates their clonal derivation. Here, we discuss the properties, location, division‐potential, senescence, and plasticity associated with mammary epithelial stem cells and present the developing evidence for their presence in human breast and their important role in the risk for breast cancer development. Further, we review the present morphologic and genetic evidence for the characterization of specific stem cell markers and lineage‐limited progenitor cells in human and rodent mammary epithelium. Microsc. Res. Tech. 52:190–203, 2001. Published 2001 Wiley‐Liss, Inc.


  • Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice

    by Cs Atwood, Rc Hovey, Jp Glover, G Chepko, E Ginsburg, Wg Robison, Bk Vonderhaar

    Development of the functional secretory epithelium in the mammary gland of the female mouse requires the elongation of the anlage through the mammary fat pad to form the primary/secondary ductal network from which tertiary ductal side-branches and lobuloalveoli develop. In this study we examined the hormonal requirements for the spatial development of the primary/secondary epithelial network and tertiary side-branches by quantifying ductal growth and epithelial cell proliferation in normal and hormone-treated BALB/c mice between 21 and 39 days of age. In normal mice, an allometric increase in ductal length commenced at 31 days of age and resulted in completion of the primary/secondary ductal network by 39 days of age. Concurrent with this allometric growth was a significant increase in cellular proliferation in the terminal end-buds (TEBs) of the ductal epithelium from 29 days of age, as determined by 5-bromo-2'-deoxyuridine (BrdU) incorporation. A level of cellular proliferation similar to that in the TEBs of 33-day-old control mice could be induced in the TEBs of 25-day-old mice following treatment for 1 day with estrogen (E), or progesterone (P) or both (E/P), indicating that both E and P were mitogenic for epithelial cells of the peripubertal TEBs. However, the period of allometric ductal growth in untreated mice did not correspond to an increase in serum E or P (which might have been expected during the estrous cycle). In addition, epithelial growth was not observed in mammary glands from 24-day-old mice that were cultured in vitro with E, P or E/P. In contrast to treatment with E, treatment with P promoted a dramatic increase, relative to control mice, in the number of tertiary branch points upon the primary/secondary ductal network. BrdU labeling of mammary glands from 24- 33-day-old mice pelleted with cholesterol (C), E, P or E/P confirmed the greater mitogenicity of P on the epithelial cells of the secondary/tertiary ducts as compared with C or E. Concurrent with these changes, localized progesterone receptor (PR) expression in clusters of cells in the ductal epithelium was associated with structures that histologically resembled early branch points from ductules. In conclusion, our results suggest that additional endocrine growth factor(s) other than E and P contribute to the development of the primary/secondary ductal network, and that P is responsible for the formation of tertiary side-branches in the mammary glands of mice during puberty.


  • Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis

    by Dezhong J Liao, Geraldine Natarajan, Sandra L Deming, M Hunter Jamerson, Michael Johnson, Gloria Chepko, Robert B Dickson

    Using single and double transgenic mouse models, we investigated how c-Myc modulates the mammary epithelial cell cycle to induce cancer and how TGFalpha enhanced the process. In c-myc transgenic mice, c-myc expression was high in the hyperplastic mammary epithelium and in the majority of tumor areas. However, the tumors displayed focal areas of low expression of c-myc but high rates of proliferation. In contrast to E2F1 and cyclin A2, which were induced and co-localized with c-myc expression, induction of cyclins D1 and E occurred only in these tumor foci. Overexpression of cyclin D1 also occurred in the hyperplastic epithelium of tgfalpha-single and tgfalpha/c-myc-double transgenic mice. In tgfalpha/c-myc tumors, cells positive for cyclins D1 and E were randomly spread, without showing a reciprocal relationship to c-myc expression. In contrast to c-myc tumors, most tgfalpha/c-myc tumors showed undetectable levels of retinoblastoma protein (pRB), and the loss of pRB occurred in some cases at the mRNA level. These results suggest that E2F1 and cyclin A2 may be induced by c-Myc to mediate the onset of mammary cancer, whereas overexpression of cyclins D1 and E may occur later to facilitate tumor progression. TGFalpha may play its synergistic role, at least in part, by inducing cyclin D1 and facilitating the loss of pRB.


  • Mammary Epithelial Stem Cells: Our Current Understanding

    by Gloria Chepko, Gilbert H. Smith

    It has recently been shown that the progeny froma single cell may comprise the epithelial population ofa fully developed lactating mammary outgrowth in mice.Serial transplantation of epithelial...